presentationandclinicalsymptomatologyof
inneonatesandinfants,850–851
inolderchildrenandadults,851
prevalenceandetiologyof,843–844
surgicalmanagementof,857–858
extra-anatomicbypassgraftsfor,858
interpositiongraftsfor,858
leftsubclavianpatchaortoplastyfor,857–858,857f
otherapproachesfor,858
patchaortoplastyfor,858,858f
resectionandend-to-endrepairfor,857
transpositionofthegreatarterieswith,surgicalmanagementof,689
Cohortstudies,415–417
Collaboration,networksand,improvingoutcomesincongenitalheartcare,
1515–1516,1515t
Collagensynthesisdisorders,cardiacinvolvementin,1098–1102
Collagens,1356
Collateralflow,327
ColorDoppler,fetal,126–127
ColorflowDopplerechocardiography,284–285
imageacquisitionin,311
optimizingsettingsfor,286
three-dimensional,316
Combinationtherapy,forpulmonaryhypertension,1390
Combinedcardiacoutput(CCO),160
Comettail,onultrasoundimages,283
Commonarterialtrunk,318t,741–753
anatomyof,741–745,742f–744f
angiocardiographyin,750–751,751f
cardiaccatheterizationin,750–751,751f
diagnosticfeaturesof,745–747
antenataldiagnosis,745–746
electrocardiographyin,747
neonatalpresentation,746–747
incidenceof,741
keydiagnosticfeaturesin,747t
morphogenesisof,745,746f
outcomesaftersurgeryfor,752–753,753f
radiologicfeaturesof,747–750,747f
echocardiographyin,748–750,748f–750f
recommendationsforlong-termfollowup,753
surgicaltreatmentin,751–752,752f
Communications
arteriovenous,927–944
emergingresourcestoimprove,1488,1489f
tofamilies,1492,1493f
long,1493
modesof,1490–1492,1492f
patientcaretransitions,keyfor,1487–1488
withpatientsandfamilies,1463
toreducebarrierstocare,1488,1489b
withteamprovidingcare,inambulatorysettingand“medicalhome,”,1487–1494
case1,1487–1488
case2,1490–1492
case3,1492–1493
Community,cardiologistasresourcefor,1494
Compassionateterminalcare,1466t
Completeheartblock,143,375,376f
Completemechanicalsupport,foracutecirculatoryfailure,1186–1187
Complexcardiacdisease,insettingofseveregeneticcondition,1470–1471
Complexcirculations,incardiovasculardrugs,1185
Complexcongenitalcardiacdisease
anesthesiafor,1400
benzodiazepinesfor,1400
cardiacsurgery,onbrain,1397–1399,1398b
anesthesiain,1399
cardiopulmonarybypassstrategyin,1398–1399
hematocritduringbypass,1399
pHmanagementin,1399
earlyinterventionsfor,1401
health-relatedqualityoflifein,1403–1404
scoresinpediatriccardiacandcongenitalheartdiseasesurvivors,1403
variationin,scoresincongenitalheartdiseasesurgicalsurvivors,1403–1404,1403f
initialintensivecareunitstayandlivingwith,longer-termeffectsof,1405–1406
mentalhealth,1406
onpatient-parentdyadandposttraumaticstressdisorder,1405–1406,1405f
siblingeffect,1406
intensivecareunit,developmentalcarein,1400–1401,1400b,1401t
mechanismsof,1394–1396,1395f
braininjury,prenatalmechanismsof,1394
fetalcerebrovascularphysiology,oxygendelivery,andplacenta,1394–1396
narcoticsfor,1400
neurodevelopmentalandpsychosocialoutcomesin,1393–1406
cardiacdiagnosison,1397
cardiacneurodevelopmentalprogramsfor,1402
developmentalandschoolservicesfor,1402,1402b
emergingdataon,1404–1405
evaluationandmanagementof,strategiesfor,1401–1402,1402b
neurodevelopmentalandpsychosocialphenotypein,1393–1394,1394b
neurologicinjuryanddevelopmentaldisability,geneticsusceptibilityto,1397
newbornmanifestationsof,1396–1397
decreasedcentralnervousmaturity,1396
microcephaly,1396
periventricularleukomalacia/whitematterinjury,1396–1397
postoperativefactorsfor,1399–1400
hemodynamicinstabilityin,1399–1400
lengthofstay,1400
seizuresin,1400